Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01079598 · ClinicalTrials.gov registry record · NA
RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study
A NA study, sponsored by Medtronic Endovascular.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01079598 is a NA study that was terminated before completion, run by Medtronic Endovascular. The registered enrollment target is 8 participants.
The verdict
NCT01079598, a NA study, was terminated before completion, sponsored by Medtronic Endovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that patients will improve the immediate treatment outcomes from successive radiofrequency ablation (RFA) of incompetent perforator veins (IPVs).
Interventions
- DEVICE RF Ablation (ClosureRFS Stylet)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01079598
The ClinicalTrials.gov registry entry for NCT01079598 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF Ablation (ClosureRFS Stylet) is the first listed.
NCT01079598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01079598 about?
NCT01079598 is a clinical study titled "RFS (Radiofrequency Stylet) - Radiofrequency Perforator Vein Treatment Study". The purpose of this study is to demonstrate that patients will improve the immediate treatment outcomes from successive radiofrequency ablation (RFA) of incompetent perforator veins (IPVs).
What is the current status of trial NCT01079598?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2010-03. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01079598?
The interventions under investigation include: RF Ablation (ClosureRFS Stylet) (DEVICE).
Who is sponsoring clinical trial NCT01079598?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.